Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Effect of cyclooxygenase-2 inhibition by meloxicam, on atrogin-1 and myogenic regulatory factors in skeletal muscle of rats injected with endotoxin.

Martin AI, Nieto-Bona MP, Castillero E, Fernandez-Galaz C, Lopez-Menduina M, Gomez-Sanmiguel AB, Gomez-Moreira C, Villanua MA, Lopez-Calderon A.

J Physiol Pharmacol. 2012 Dec;63(6):649-59.

2.

Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors.

Castillero E, Martín AI, López-Menduiña M, Villanúa MA, López-Calderón A.

Am J Physiol Regul Integr Comp Physiol. 2009 Nov;297(5):R1322-31. doi: 10.1152/ajpregu.00388.2009. Epub 2009 Sep 9.

3.

Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.

Granado M, Martín AI, Villanúa MA, López-Calderón A.

Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1656-65. Epub 2007 Feb 6.

4.

D-TRP(8)-γMSH Prevents the Effects of Endotoxin in Rat Skeletal Muscle Cells through TNFα/NF-KB Signalling Pathway.

Gómez-SanMiguel AB, Villanúa MÁ, Martín AI, López-Calderón A.

PLoS One. 2016 May 13;11(5):e0155645. doi: 10.1371/journal.pone.0155645. eCollection 2016.

5.

Joint inflammation alters gene and protein expression and leads to atrophy in the tibialis anterior muscle in rats.

Ramírez C, Russo TL, Sandoval MC, Dentillo AA, Couto MA, Durigan JL, Salvini TF.

Am J Phys Med Rehabil. 2011 Nov;90(11):930-9. doi: 10.1097/PHM.0b013e31822dea3c.

PMID:
21959222
6.

αMSH blunts endotoxin-induced MuRF1 and atrogin-1 upregulation in skeletal muscle by modulating NF-κB and Akt/FoxO1 pathway.

Martín AI, Gómez-SanMiguel AB, Gómez-Moreira C, Villanúa MÁ, López-Calderón A.

Mediators Inflamm. 2014;2014:179368. doi: 10.1155/2014/179368. Epub 2014 Sep 9.

7.

Actions of short-term fasting on human skeletal muscle myogenic and atrogenic gene expression.

Larsen AE, Tunstall RJ, Carey KA, Nicholas G, Kambadur R, Crowe TC, Cameron-Smith D.

Ann Nutr Metab. 2006;50(5):476-81. Epub 2006 Aug 24.

PMID:
16931880
8.

Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3.

López-Menduiña M, Martín AI, Castillero E, Villanúa MA, López-Calderón A.

Am J Physiol Regul Integr Comp Physiol. 2010 Aug;299(2):R541-51. doi: 10.1152/ajpregu.00211.2010. Epub 2010 Jun 2.

9.

Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy.

Castillero E, Nieto-Bona MP, Fernández-Galaz C, Martín AI, López-Menduiña M, Granado M, Villanúa MA, López-Calderón A.

Am J Physiol Endocrinol Metab. 2011 May;300(5):E790-9. doi: 10.1152/ajpendo.00590.2010. Epub 2011 Feb 8.

10.

Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.

Castillero E, Alamdari N, Lecker SH, Hasselgren PO.

Metabolism. 2013 Oct;62(10):1495-502. doi: 10.1016/j.metabol.2013.05.018. Epub 2013 Jul 15.

PMID:
23866982
11.

Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle.

Frost RA, Nystrom GJ, Jefferson LS, Lang CH.

Am J Physiol Endocrinol Metab. 2007 Feb;292(2):E501-12. Epub 2006 Sep 26.

12.

Branched-chain amino acids reduce hindlimb suspension-induced muscle atrophy and protein levels of atrogin-1 and MuRF1 in rats.

Maki T, Yamamoto D, Nakanishi S, Iida K, Iguchi G, Takahashi Y, Kaji H, Chihara K, Okimura Y.

Nutr Res. 2012 Sep;32(9):676-83. doi: 10.1016/j.nutres.2012.07.005. Epub 2012 Sep 17.

PMID:
23084640
13.

IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting.

Castillero E, Martín AI, López-Menduiña M, Granado M, Villanúa MA, López-Calderón A.

Mol Cell Endocrinol. 2009 Oct 15;309(1-2):8-16. doi: 10.1016/j.mce.2009.05.017. Epub 2009 Jun 6.

PMID:
19501629
14.

Acute alcohol intoxication increases atrogin-1 and MuRF1 mRNA without increasing proteolysis in skeletal muscle.

Vary TC, Frost RA, Lang CH.

Am J Physiol Regul Integr Comp Physiol. 2008 Jun;294(6):R1777-89. doi: 10.1152/ajpregu.00056.2008. Epub 2008 Apr 9.

15.

Cyclooxygenase-2 [corrected] activation by endotoxin mediates the decrease in IGF1, but not in IGFBP3, [corrected] gene expression in the liver.

Martín AI, López-Menduiña M, Castillero E, Granado M, Villanúa MA, López-Calderón A.

J Endocrinol. 2008 Aug;198(2):385-94. doi: 10.1677/JOE-08-0205. Epub 2008 May 20. Erratum in: J Endocrinol. 2008 Dec;199(3):501.

16.

Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.

Gonçalves DA, Lira EC, Baviera AM, Cao P, Zanon NM, Arany Z, Bedard N, Tanksale P, Wing SS, Lecker SH, Kettelhut IC, Navegantes LC.

Endocrinology. 2009 Dec;150(12):5395-404. doi: 10.1210/en.2009-0428. Epub 2009 Oct 16.

PMID:
19837877
17.

[Effect of Ligustrazine on expressions of FoXO3a, MAFbx, and MuRF1 in denervated skeletal muscle atrophy rats].

Wang H, Liang B, Peng C, Wang P.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 May;26(5):597-600. Chinese.

PMID:
22702057
18.

The effect of 30 minutes of passive stretch of the rat soleus muscle on the myogenic differentiation, myostatin, and atrogin-1 gene expressions.

Gomes AR, Soares AG, Peviani S, Nascimento RB, Moriscot AS, Salvini TF.

Arch Phys Med Rehabil. 2006 Feb;87(2):241-6.

PMID:
16442979
19.

Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I.

Lang CH, Huber D, Frost RA.

Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R328-36. Epub 2006 Aug 31.

20.

Androgenic and estrogenic regulation of Atrogin-1, MuRF1 and myostatin expression in different muscle types of male mice.

De Naeyer H, Lamon S, Russell AP, Everaert I, De Spaey A, Vanheel B, Taes Y, Derave W.

Eur J Appl Physiol. 2014 Apr;114(4):751-61. doi: 10.1007/s00421-013-2800-y. Epub 2014 Jan 5.

PMID:
24390687

Supplemental Content

Support Center